Event JSON
{
"id": "6a504bf8ef3f1e11af474ff933279f58f22c0d132bb2e0469d13a7fcb0fa49c9",
"pubkey": "0b32dfc9f17bbcade06401bc0c73380682824773cd0c566a578042425604a33b",
"created_at": 1719500581,
"kind": 1,
"tags": [
[
"t",
"healthcare"
],
[
"t",
"insurance"
],
[
"t",
"obesity"
],
[
"t",
"weightloss"
],
[
"t",
"phrma"
],
[
"t",
"drugprices"
],
[
"t",
"prescriptiondrugs"
],
[
"proxy",
"https://med-mastodon.com/users/bicmay/statuses/112689190085730441",
"activitypub"
]
],
"content": "“Pretty much everyone is the same,” she said. “They say: ‘I’d love to treat obesity. I’d love to help people. It’s just too expensive.’ But you can’t not treat cancer because it’s too expensive. Why can you do that with obesity?” \n\nhttps://www.nytimes.com/2024/06/25/health/obesity-ozempic-wegovy-west-virginia.html\n\n#healthcare #insurance #obesity #WeightLoss #PhRMA #DrugPrices #PrescriptionDrugs",
"sig": "d129ce8a4e5e886ee1c8643c787ee93cbb9e3c713bd6ab069a2a2200403040914769de4410bd78a945adc021f855a03a606f3cc49eed188835b14b8fd17b2653"
}